Insider Trading

W. Michael Flanagan Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 1 week ago

W. Michael Flanagan has an estimated net worth of at least $12.7 million*, as of Dec. 18, 2024. They own 72,647 shares of RNA stock. They have sold 249,871 shares of RNA stock since 2021, for an estimated $9.9 million.

W. Michael Flanagan $RNA SEC Form 4 Insider Trading

W. Michael Flanagan has filed a total of 10 insider trades in $RNA since 2021. Their most recent trade was a sale of 12,742 shares, made on Dec 18, 2024. Their largest trade was a sale of 62,500 shares, made on Oct 01, 2024. We estimate that they now own 72,647 shares of $RNA, worth an estimated $2.8 million.



Insider Trading at $RNA

There have been a total of 81 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.0 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Arthur A Levin, and Michael F Maclean. The most recent trade was a sale of 12,742 shares reported by W. Michael Flanagan (CSTO), made on Dec 18, 2024.



History of Insider Stock Trades by W. Michael Flanagan

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
RNA Sale 12,742 Dec 18, 2024 Dec. 19, 2024, 7:17 p.m.
RNA Sale 24,000 Dec 11, 2024 Dec. 13, 2024, 7:08 p.m.
RNA Sale 62,500 Oct 01, 2024 Oct. 3, 2024, 4:09 p.m.
RNA Sale 11,847 Sep 23, 2024 Sept. 23, 2024, 9:03 p.m.
RNA Sale 13,153 Sep 23, 2024 Sept. 23, 2024, 9:03 p.m.
RNA Sale 62,500 Sep 11, 2024 Sept. 13, 2024, 4:25 p.m.
RNA Sale 34,000 Sep 11, 2024 Sept. 13, 2024, 4:25 p.m.
RNA Sale 14,894 Sep 11, 2024 Sept. 13, 2024, 4:25 p.m.
RNA Sale 10,106 Jun 18, 2024 June 20, 2024, 6:47 p.m.
RNA Sale 4,129 Jan 22, 2024 Jan. 23, 2024, 4:12 p.m.




$RNA Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.